Built Environment as a Dangerous Ecosystem
Main Article Content
Abstract
For millennia, damp and musty buildings have been linked to human illness, as noted in ancient texts, including Leviticus 14. Today, the modern equivalent of priestly oversight falls to Indoor Environmental Professionals (IEPs), who serve as a bridge between clinical understanding and the physical assessment and remediation of structures. This paper—Part B of a three-part series—advances the evolving recognition of the built environment as a medically relevant ecosystem, particularly for individuals with complex chronic illnesses such as Chronic Inflammatory Response Syndrome (CIRS), mast cell activation disorders, and chemical sensitivities.
Building on Part A, which outlined the human health impacts of exposure to microbial and chemical agents in water-damaged buildings (WDBs), this paper reframes conventional assessment and remediation practices by introducing a medically important approach for assessing and remedying WDBs, along with measures to prevent future exposure. It emphasizes the inadequacy of superficial or cosmetic repairs when faced with persistent health symptoms, highlighting the need for a more in-depth approach that prioritizes occupant-specific sensitivities, proper removal of microbial sources, and durable restoration practices. Drawing on decades of interdisciplinary field experience, we argue that effective remediation must also extend beyond Mold-centric models and consider the broader microbial and material ecology of the indoor space.
Key recommendations include redefining thresholds for cleanliness, integrating environmental and health data in building assessments, and selecting non-sensitizing materials to support occupant recovery. The paper positions the building not merely as shelter, but as a dynamic system whose microbial composition can either impede or facilitate healing. By bridging insights from building science, environmental health, and clinical medicine, this work lays the groundwork for transdisciplinary collaboration.
Part C translates these environmental and diagnostic principles into an evidence-based, sequential treatment protocol—the CIRS Protocol—designed to restore health through both environmental correction and biomarker-driven clinical care. Together, this trifecta creates a comprehensive framework for addressing illness rooted in the built environment. In that paper, readers will find a detailed rationale and structure for medically important remediation (MIR), supported by field experience and multidisciplinary research. We conclude that sustainable recovery from environmentally acquired illness requires an integrated, occupant-centered approach that treats the building not only as a source of exposure, but as an active component in the healing process.
Article Details
How to Cite
SCHRANTZ, Michael et al.
Built Environment as a Dangerous Ecosystem.
Medical Research Archives, [S.l.], v. 13, n. 8, sep. 2025.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/6767>. Date accessed: 06 dec. 2025.
doi: https://doi.org/10.18103/mra.v13i8.6767.
Section
Research Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. The Holy Bible, New International Version. Leviticus 14:33–53. Grand Rapids, MI: Zondervan; 2011.
2. United States Environmental Protection Agency (EPA). Indoor Air Facts No. 4 (Revised): Sick Building Syndrome. EPA 402-F-94-004. Washington, DC: US EPA; 1991. Accessed June 20, 2025. https://www.epa.gov/sites/default/files/2014-08/documents/sick_building_factsheet.pdf
3. World Health Organization (WHO). Indoor Air Quality: Biological Contaminants: Report on a WHO Meeting. European Series No. 31. Copenhagen, Denmark: WHO Regional Office for Europe; 2009. Accessed June 20, 2025. https://iris.who.int/handle/10665/260557
4. Sundell J. What we know, and don't know about sick building syndrome. ASHRAE J. 1996;38(6).
5. Seppänen O, Fisk WJ, Mendell MJ. Association of ventilation rates and CO₂ concentrations with health and other responses in commercial and institutional buildings. Indoor Air. 1999;9(4):226–252. doi:10.1111/j.1600-0668.1999. 00003.x
6. Sundell J. On the history of indoor air quality and health. Indoor Air. 2004;14(Suppl 7):51–58. doi:10.1111/j.1600-0668.2004. 00273.x
7. Joshi SM. The sick building syndrome. Indian J Occup Environ Med. 2008 ;12(2) :61–64.
8. Chawla H, Anand P, Garg K, et al. A comprehensive review of microbial contamination in the indoor environment: sources, sampling, health risks, and mitigation strategies. Front Public Health. 2023; 11:1285393. doi:10.3389/fpubh.2023.1285393
9. New York City Department of Health. Guidelines on Assessment and Remediation of Stachybotrys atra in Indoor Environments. New York, NY: New York City Department of Health; 1993.
10. New York City Department of Health and Mental Hygiene, Bureau of Environmental & Occupational Disease Epidemiology. Guidelines on Assessment and Remediation of Fungi in Indoor Environments. New York, NY: NYC DOHMH; 2000.
11. American Conference of Governmental Industrial Hygienists. Bioaerosols: Assessment and Control. Cincinnati, OH: ACGIH; 1999.
12. US Environmental Protection Agency. Mold Remediation in Schools and Commercial Buildings. EPA 402-K-01-001. Washington, DC: US Environmental Protection Agency; 2001.
13. Górny RL, Reponen T, Willeke K, Schmechel D, Robine E, Boissier M, Grinshpun SA. Fungal fragments as indoor air biocontaminants. Appl Environ Microbiol. 2002;68(7):3522–3531. doi:10.1128/AEM.68.7.3522-3531.2002
14. Górny RL, Reponen T, Willeke K, et al. Release of fungal fragments in relation to fungal spore release from contaminated building materials. J Aerosol Sci. 2002;33(10):1319–1332. doi:10.1016/S0021-8502(02)00066-9
15. Brasel TL, Martin JM, Carriker CG, Wilson SC, Straus DC. Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins on particulates smaller than conidia. Appl Environ Microbiol. 2005;71(1):114–122. doi:10.1128/AEM.71.1.114-122.2005
16. Cho SH, Seo SC, Schmechel D, Grinshpun SA, Reponen T. Aerodynamic characteristics and respiratory deposition of fungal fragments. Atmos Environ. 2005;39(30):5454–5465. doi: 10.1016/j.atmosenv.2005.05.029
17. Reponen T, Seo SC, Grimsley F, Lee T, Crawford C, Grinshpun SA. Fungal fragments in moldy houses: a field study in homes in New Orleans and southern Ohio. Atmos Environ. 2007;41(37):8140–8149. doi: 10.1016/j.atmosenv.2007.06.004
18. Adhikari A, Reponen T, Rylander R. Airborne fungal cell fragments in homes in relation to total fungal biomass. Indoor Air. 2013;23(1):1–6. doi:10.1111/j.1600-0668.2012. 00799.x
19. Seo SC, Ji YG, Yoo Y, Kwon MH, Choung JT. Submicron fungal fragments as another indoor biocontaminant in elementary schools. Environ Sci Process Impacts. 2015;17(6):1164–1172. doi:10.1039/c5em00104k
20. Lee T, Grimsley F, Seo SC, Reponen T, Grinshpun SA. The level of submicron fungal fragments in homes with asthmatic children. Environ Res. 2014; 131:71–76. doi: 10.1016/j.envres.2014.02.014
21. Institute of Inspection, Cleaning and Restoration Certification (IICRC). IICRC S500: Standard and Reference Guide for Professional Water Damage Restoration. 2nd ed. Vancouver, WA: IICRC; 1999.
22. Institute of Inspection, Cleaning and Restoration Certification (IICRC). IICRC S520: Standard and Reference Guide for Professional Mold Remediation. 1st ed. Vancouver, WA: IICRC; 2003.
23. Institute of Inspection, Cleaning and Restoration Certification (IICRC). ANSI/IICRC S520-2024: Standard for Professional Mold Remediation. 4th ed. Las Vegas, NV: Institute of Inspection, Cleaning and Restoration Certification; 2024.
24. Banta JC, Passmore C, Holland J. Modeling the equilibrium spore load of a building. In: Johanning E, ed. Bioaerosols, Fungi, Bacteria, Mycotoxins, and Human Health. Albany, NY: Fungal Research Group Foundation; 2005:262–269.
25. Hardin BD, Kelman BJ, Saxon A. Adverse human health effects associated with molds in the indoor environment. J Occup Environ Med. 2003;45(5):470–478. doi: 10.1097/01.jom.0000069239.19784.5b
26. Kelman BJ. Deposition of Bruce J. Kelman (Kelman & GlobalTox, Inc. v. Kramer). July 22, 2008. Accessed July 1, 2025. https://katysexposure.com/wp-content/uploads/2021/03/kelman-deposition-july-22-2008-kelman-and-globaltox-v-kramer.pdf
27. Kramer S. Petition for Rehearing, Case No. D054496 / D047758, California Court of Appeal. October 22, 2010. Accessed July 1, 2025. https://katysexposure.com/wp-content/uploads/2021/03/10.22.10-final-petition-to-ca-supreme-ct-w-exhibilts.pdf
28. Mold-Help.org. Mold health rights advocate is sued by GlobalTox (now Veritox). Published June 2006. Accessed July 1, 2025. https://www.mold-help.org/mold-health-rights-advocate-sued-by-globaltox-now-veritox
29. Adamy J. Amid suits over mold, experts wear two hats. Wall Street Journal. February 7, 2007. Reprinted by WonderMakers Environmental. Accessed July 1, 2025. https://www.wondermakers.com/Portals/0/docs/02.%20Amid%20Suits%20Over%20Mold%20Experts%20Wear%20Two%20Hats%2002.07.pdf
30. Craner J. A critique of the ACOEM statement on mold: undisclosed conflicts of interest in the creation of an "evidence-based" statement. Int J Occup Environ Health. 2008;14(4):283–298. doi:10.1179/oeh.2008.14.4.283
31. Storey E, Dangman KH, Schenck P, et al. Guidance for Clinicians on the Recognition and Management of Health Effects Related to Mold Exposure and Moisture Indoors. Farmington, CT: University of Connecticut Health Center, Division of Occupational and Environmental Medicine, Center for Indoor Environments and Health; 2004.
32. Haugland RA, Vesper SJ. Method of identifying and quantifying specific fungi and bacteria. US patent 6,387,652 B1. May 14, 2002. Assigned to the US Environmental Protection Agency.
33. Vesper SJ. Mold specific quantitative PCR for rapid identification and enumeration. Presented at: 7th Annual Army Force Health Protection Conference; August 6–12, 2004; Albuquerque, NM.
34. Vesper SJ, Haugland C, Barnes C, Reponen F, Grinshpun SA. Development of an environmental relative moldiness index for US homes. Appl Environ Microbiol. 2007;73(11):346–356.
35. Vesper SJ. The development and application of the Environmental Relative Moldiness Index (ERMI). Crit Rev Microbiol. 2024;51(2):285–295. doi:10.1080/1040841X.2024.2344112
36. World Health Organization. WHO Guidelines for Indoor Air Quality: Dampness and mold. Copenhagen, Denmark: WHO Regional Office for Europe; 2009.
37. Institute of Medicine (US) Committee on Damp Indoor Spaces and Health. Damp Indoor Spaces and Health. Washington, DC: National Academies Press; 2004. Chapter 6, Prevention and remediation of damp indoor environments. Accessed July 1, 2025. https://www.ncbi.nlm.nih.gov/books/NBK215647/
38. American National Standards Institute (ANSI). ANSI Essential Requirements: Due Process Requirements for American National Standards. ANSI; 2024. Accessed July 1, 2025. https://www.ansi.org/essentialrequirements
39. US Government Accountability Office. Indoor Mold: Better Coordination of Research on Health Effects and More Consistent Guidance Would Improve Federal Efforts. GAO-08-980. Washington, DC: US Government Accountability Office; September 2008.
40. Shoemaker RC, Johnson K, Jim L, et al. Diagnostic process for chronic inflammatory response syndrome (CIRS): a consensus statement. Intern Med Rev. 2018;4(5):1–47.
41. Shoemaker RC, Lark D. HERTSMI-2 and ERMI: correlating human health risk with mold-specific qPCR in water-damaged buildings. Presented at: 14th International Conference on Indoor Air Quality and Climate; May 2016; Ghent, Belgium.
42. Shoemaker RC, House DE. Sick building syndrome in water-damaged buildings: generalization of the chronic biotoxin-associated illness paradigm to indoor toxigenic fungi exposure. Neurotoxicol Teratol. 2006;28(5):573–588. doi: 10.1016/j.ntt.2006.07.007
43. Shoemaker RC, Maizel M. Exposure to water-damaged buildings causes a readily identifiable chronic inflammatory response syndrome that is successfully treated by a sequential intervention protocol. Presented at: International Mycological Congress 9; 2010; Edinburgh, Scotland.
44. Flannigan B, Samson RA, Miller JD, eds. Microorganisms in Home and Indoor Work Environments: Diversity, Health Impacts, Investigation and Control. London, UK: Taylor & Francis; 2001.
45. Banta JC. Mold Controlled: A Guide to Finding, Fixing, Preventing, and Getting Help with Mold Problems in Homes. John C. Banta Publishing; 2025.
46. CIRSx Institute. Medically Important Remediation for Professionals (MIR 101) [online course]. 14 CE hours. CIRSx Institute; 2024. Accessed July 1, 2025. https://institute.cirsx.com/course/mir101
47. Halverson M, Christian J. Managing the drivers of airflow and water vapor transit in existing buildings. Building America Technical Update. US Department of Energy; April 2011.
48. US Department of Housing and Urban Development. Minimizing Moisture Problems in Manufactured Homes: Response of Interior Air Pressures to Operating Conditions. HUD; June 2003.
49. World Health Organization. Moisture Control Guidance for Building Design, Construction, and Maintenance. Adapted by US Environmental Protection Agency; December 2013.
50. Schwartz L, Schrantz M, Weatherman G, Charlton J, Shoemaker R. Surviving Mold Consensus Statement: Medically Sound Investigation and Remediation of Water-Damaged Buildings in Cases of CIRS-WDB. SurvivingMold.com; 2016. Accessed July 1, 2025. https://www.survivingmold.com/docs/IEP_CONSENSUS_04_12_16.pdf
51. CIRSx Institute. Medically Important Assessment for Professionals (MIA 101) [online course]. CIRSx Institute; 2024. Accessed July 1, 2025. https://institute.cirsx.com/payment?product_id=mia101
52. CIRSx Institute. Medically Important Assessment for Consultants (MIA 102) [online course]. CIRSx Institute; 2024. Accessed July 1, 2025. https://institute.cirsx.com/payment?product_id=mia102
53. Lstiburek JW, Eng P. Understanding vapor barriers. ASHRAE J. 2004; 46:40–51.
54. Lstiburek JW. Toward an Understanding and Prediction of Air Flow in Buildings [doctoral dissertation]. 2000.
55. Lstiburek J, Pressnail K, Timusk J. Air pressure and building envelopes. J Therm Envel Build Sci. 2002;26(1):53–91. doi:10.1177/1097196302026001570
56. Lstiburek J. Moisture control for buildings. ASHRAE J. 2002;44(2):36–41.
57. Lstiburek JW. The Pressure Response of Buildings. 1998.
58. Cox DJ, Seitz RW, Anderson RA. Mold growth and carbon dioxide production during storage of moist grain. Cereal Chem. 1985;62(2):137–142.
59. Smith J, Rhoades M, Taylor C, et al. Assessment of microbial activity by CO₂ production during heating-oil storage. Appl Environ Microbiol. 2023; e00934-23. doi:10.1128/aem.00934-23
60. Koruba D, Piotrowski JZ. Effect of high CO₂ concentrations on the molds' growth and morphology present in the indoor air. Proc Kielce Univ Technol Fac Civil Environ Eng Sect. 2021.
61. United States Environmental Protection Agency. Mold course chapter 1: introduction to molds. EPA. December 20, 2024. Accessed June 20, 2025. https://www.epa.gov/mold/mold-course-chapter-1
62. Centers for Disease Control and Prevention. Mold prevention strategies and possible health effects in the aftermath of hurricanes and major floods. MMWR Recomm Rep. 2006;55(RR-8):1–27. Accessed June 20, 2025. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5508a1.htm
63. Cho SH, Seo SC, Schmechel D, Grinshpun SA, Reponen T. Aerodynamic characteristics and respiratory deposition of fungal fragments. Atmos Environ. 2005;39(30):5454–5465. doi: 10.1016/j.atmosenv.2005.05.029
64. Reponen T, Seo SC, Grimsley F, Lee T, Crawford C, Grinshpun SA. Fungal fragments in moldy houses: a field study in homes in New Orleans and southern Ohio. Atmos Environ. 2007;41(37):8140–8149. doi: 10.1016/j.atmosenv.2007.06.004
65. Hooke R. Micrographia: or Some Physiological Descriptions of Minute Bodies Made by Magnifying Glasses. London, UK: J. Martyn and J. Allestry; 1665.
66. Black WD. A comparison of several media types and basic techniques used to assess outdoor airborne fungi in Melbourne, Australia. PLoS One. 2020;15(12): e0238901. doi: 10.1371/journal.pone.0238901
67. EMSL Analytical, Inc. Microbiology Sampling Guide. Parsippany, NJ: EMSL Analytical, Inc.; 2019. Accessed July 1, 2025. https://emsl.com/PDFDocuments/SamplingGuide/Microbiology%20Sampling%20Guide.pdf
68. Flannigan B, Samson RA, Miller JD, eds. Microorganisms in Home and Indoor Work Environments: Diversity, Health Impacts, Investigation, and Control. 2nd ed. Boca Raton, FL: CRC Press; 2011:33.
69. Käpylä M, Penttinen A. An evaluation of the microscopic counting methods of the tape in Hirst-Burkard pollen and spore trap. Grana. 1981; 20:131–141.
70. Zhu H, Ge Y, Wang Y, et al. PCR past, present and future. Biotechniques. 2020;69(4):317–325. doi:10.2144/btn-2020-0082
71. Cox CS, Wathes CM. Bioaerosols in the environment. In: Cox CS, Wathes CM, eds. Bioaerosols Handbook. Boca Raton, FL: Lewis Publishers; 1995.
72. Nottrebart HS. Nosocomial infections acquired by hospital employees. Infect Control. 1980; 1:257–259.
73. Burge HA, Macher JM, Milton DK, Ammann HA. Data evaluation. In: Macher J, ed. Bioaerosols: Assessment and Control. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 1999.
74. Macher J, ed. Bioaerosols: Assessment and Control. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 1999.
75. Rubin J. Mycobacterial disinfection and control. In: Block SS, ed. Disinfection, Sterilization, and Preservation. 4th ed. Philadelphia, PA: Lea & Febiger; 1991.
76. Reinthaler FF, Haas D, Feierl G, et al. Comparative investigations of airborne culturable microorganisms in selected waste treatment facilities and in neighboring residential areas. Zentralbl Hyg Umweltmed. 1999; 202:1–17.
77. Reponen TA, Gazenko SV, Grinshpun SA, Willeke K, Cole EC. Characteristics of airborne actinomycete spores. Appl Environ Microbiol. 1998; 64:3807–3812.
78. Nevalainen A, Pasanen AL, Niininen M, Reponen T, Jantunen MJ, Kalliokoski P. The indoor air quality in Finnish homes with mold problems. Environ Int. 1991; 17:299–302.
79. Rautiala S, Reponen T, Hyvärinen A, et al. Exposure to airborne microbes during repair of moldy buildings. Am Ind Hyg Assoc J. 1996; 57:279–284.
80. Buttner MP, Stetzenbach LD. Monitoring of fungal spores in an experimental indoor environment to evaluate sampling methods and the effects of human activity on air sampling. Appl Environ Microbiol. 1993; 59:219–226.
81. Górny RL, Reponen T, Willeke K, Schmechel D, Robine E, Boissier M, Grinshpun SA. Fungal fragments as indoor air biocontaminants. Appl Environ Microbiol. 2002;68(7):3522–3531. doi:10.1128/AEM.68.7.3522-3531.2002
82. Lee T, Grimsley F, Seo SC, Reponen T, Grinshpun SA. The level of submicron fungal fragments in homes with asthmatic children. Environ Res. 2014; 131:71–76. doi: 10.1016/j.envres.2014.02.014
83. US Environmental Protection Agency. The Environmental Relative Moldiness Index (ERMI). EPA Science Inventory Fact Sheet; September 9, 2021.
84. Houbraken J, Frisvad JC, Samson RA, Westerdijk Fungal Biodiversity Institute. Classification of Aspergillus, Penicillium, Talaromyces, and related genera (Eurotiales): an overview of families, genera, subgenera, sections, series and species. Stud Mycol. 2021; 102:1–165. doi: 10.1016/j.simyco.2021.01.002
85. Samson RA, Frisvad JC, Hubka V, et al. Phylogeny, identification and nomenclature of the genus Aspergillus. Stud Mycol. 2014; 78:141–173. doi: 10.1016/j.simyco.2014.07.004
86. Lin KT, Schrantz M, Sandagdorj O, et al. Spore trap analysis and MSQPCR in evaluating mold burden: a flooded gymnasium case study. Front Biosci (Elite Ed). 2011;3(1):108–114.
87. Meklin T, Reponen T, McKinstry C, et al. Comparison of mold concentrations quantified by MSQPCR in indoor and outdoor air sampled simultaneously. Sci Total Environ. 2007;382(1):130–134. doi: 10.1016/j.scitotenv.2007.04.031
88. Lignell U, Meklin T, Rintala H, et al. Evaluation of quantitative PCR and culture methods for detection of house dust fungi and Streptomycetes in relation to moisture damage of the house. Lett Appl Microbiol. 2008;47(4):303–308. doi:10.1111/j.1472-765X.2008. 02441.x
89. Reponen T, Cho SH, Grinshpun SA, et al. Comparison of qPCR and culture-based methods for assessing indoor fungal exposure in homes with asthmatic children. Environ Sci Technol. 2008;42(7):2532–2538. doi:10.1021/es0715973
90. Vesper SJ. Traditional mold analysis compared to a DNA-based method of mold analysis. Crit Rev Microbiol. 2011;37(1):15–24. doi:10.3109/1040841X.2010.506177
91. Amin H, Balyan R, Patel K, et al. Indoor airborne microbiome and endotoxin: meteorological events and occupant characteristics are important determinants. Environ Sci Technol. 2023;57(32):11750–11766. doi: 10.1021/acs.est.3c02513
92. Amin H, Patel K, Balyan R, et al. Optimization of bacterial DNA and endotoxin extraction from settled airborne dust. Sci Total Environ. 2023; 857:159455. doi: 10.1016/j.scitotenv.2022.159455
93. Dungan RS, Leytem AB. Airborne endotoxin concentrations at a large open-lot dairy in southern Idaho. J Environ Qual. 2009;38(5):1919–1923. doi:10.2134/jeq2008.0459
94. Eduard W. Exposure to non-infectious microorganisms and endotoxins in agriculture. Ann Agric Environ Med. 1997;4(2):17–26.
95. Gioffrè A, Marramao A, Iannò A. Airborne microorganisms, endotoxin, and dust concentration in wood factories in Italy. Ann Occup Hyg. 2012;56(2):161–169. doi:10.1093/annhyg/mer089
96. Lang-Yona N, Aboaba O, Levin Y, et al. Air-sampled filter analysis for endotoxins and DNA content. J Vis Exp. 2016;(109): e53444. doi:10.3791/53444
97. Laitinen S, Kangas J, Kotimaa M, et al. Exposure to biological and chemical agents at biomass power plants. Biomass Bioenergy. 2016; 93:78–86. doi: 10.1016/j.biombioe.2016.06.003
98. Madsen AM. Airborne endotoxin in different background environments and seasons. Ann Agric Environ Med. 2006;13(1):81–86.
99. Rolph CA, Sunderraj T, Bowatte G, Lodge K, Jalaludin B, Knibbs LD. Sources of airborne endotoxins in ambient air and exposure of nearby communities—a review. Atmosphere. 2018;9(10):375. doi:10.3390/atmos9100375
100. Semple S, Apsley A, Azmina Ibrahim T, Turner S. Airborne endotoxin concentrations in homes burning biomass fuel. Environ Health Perspect. 2010;118(7):988–991. doi:10.1289/ehp.0901505
101. Shin SJ, Lee JY, Jeon BH, et al. Major environmental characteristics of swine husbandry that affect exposure to dust and airborne endotoxins. J Toxicol Environ Health A. 2019;82(4):233–243. doi:10.1080/15287394.2019.1596311
102. Siegel PD, Olenchock SA, Sorenson WG, et al. Histamine and endotoxin contamination of hay and respirable hay dust. Scand J Work Environ Health. 1991;17(4):276–280. doi:10.5271/sjweh.1705
103. Wheeler AJ, Stewart I, Donovan NJ, et al. Residential indoor and outdoor coarse particles and associated endotoxin exposures. Atmos Environ. 2011;45(39):7064–7071. doi: 10.1016/j.atmosenv.2011.09.007
104. Chhetry BS, Ahmad H, Jain R, Kumar S, Gaur R. Endotoxins affecting human health during agricultural practices: an overview. ApplChem. 2022;3(1):11–31. doi:10.3390/applchem3010002
105. Farokhi A, Heederik D, Smit LAM. Respiratory health effects of exposure to low levels of airborne endotoxin—a systematic review. Environ Health. 2018; 17:36. doi:10.1186/s12940-018-0380-6
106. Mendy A, Wilkerson J, Salo P, et al. Endotoxin clustering with allergens in house dust and asthma outcomes in a US national study. Environ Health. 2020; 19:28. doi:10.1186/s12940-020-00584-2
107. Thorne PS, Duchaine C. Airborne bacteria and endotoxin. In: Hurst CJ, Crawford RL, Garland JL, Lipson DA, Mills AL, Stetzenbach LD, eds. Manual of Environmental Microbiology. 3rd ed. Washington, DC: ASM Press; 2007:989–1004.
108. Douwes J, Thorne P, Pearce N, Heederik D. Endotoxin exposure in the workplace and residential environments: an overview of the health effects. Ann Agric Environ Med. 2002;9(2):253–268.
109. Shoemaker RC, Heyman A, Dorninger E, McMahon S, Lark D. A novel therapeutic approach to Parkinson's disease: using transcriptomics to identify unique patterns of gene expression including "triple positives," toll receptors, and endotoxin exposure. Med Res Arch. 2024;12(9). Accessed July 1, 2025. https://journals.ke-i.org/index.php/mra/article/view/6652
110. Fei-Yong Z, Zhang O, Zhang J, Lou Z, et al. The synergy of aging and LPS exposure in a mouse model of Parkinson's disease. Aging Dis. 2018; 5:785–797. doi:10.14336/AD.2018.0706
111. Brown G. The endotoxin hypothesis of neurodegeneration. J Neuroinflammation. 2019; 16:180. doi:10.1186/s12974-019-1575-2
112. Batista C, Gomes G, Candelario-Jalil E, Fiebich B, et al. Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration. Int J Mol Sci. 2019;20(9):2293. doi:10.3390/ijms20092293
113. Gu C, Wang F, Zhang Y, et al. Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming. Aging Cell. 2021;20(4): e13375. doi:10.1111/acel.13375
114. Wu L, Block M, Breese G, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55(5):453–462. doi:10.1002/glia.20467
115. Skrzypczak-Wiercioch A, Salat K. Lipopolysaccharide-induced model neuroinflammation: mechanisms of action, research application and future directions for its use. Molecules. 2022;27(2):548. doi:10.3390/molecules27020548
116. Bai L, Zhang X, Li X, et al. Somatostatin prevents LPS-induced neurodegeneration in the rat substantia nigra by inhibiting the action of microglia. Mol Med Rep. 2015;12(1):1002–1008. doi:10.3892/mmr.2015.3516
117. U.S. Food and Drug Administration. Bacterial Endotoxins/Pyrogens (USP <85>). FDA. Accessed June 20, 2025. https://www.fda.gov/media/83477/download
118. Maloney J, Nguyen HM, McMahon S. Use of recombinant factor C (rFC) assay in endotoxin testing: an alternative to Limulus amebocyte lysate. J Pharm Sci. 2021;110(4):1453–1459. doi: 10.1016/j.xphs.2020.12.012
119. Laitinen, Sirpa, et al. "Exposure to Biological and Chemical Agents at Biomass Power Plants." Biomass and Bioenergy, vol. 93, 2016, pp. 78–86.
120. Dungan RS, Leytem AB. Airborne endotoxin concentrations at a large open-lot dairy in southern Idaho. J Environ Qual. 2009;38(5):1919–1923. doi:10.2134/jeq2008.0422
121. Shin SJ, Choi SJ, Lee CH, et al. Major environmental characteristics of swine husbandry that affect exposure to dust and airborne endotoxins. J Toxicol Environ Health A. 2019;82(4):233–243. doi:10.1080/15287394.2019.1592100
122. De Rooij MMT, Smit LAM, Erbrink M, et al. Short-term residential exposure to endotoxin emitted from livestock farms in relation to lung function in non-farming residents. Environ Res. 2024; 243:117821. doi: 10.1016/j.envres.2024.117821
123. De Rooij MMT, Smit LAM, Erbrink M, et al. Endotoxin and particulate matter emitted by livestock farms and respiratory health effects in neighboring residents. Environ Int. 2019; 132:105009. doi: 10.1016/j.envint.2019.105009
124. Farokhi A, Heederik D, Smit LAM. Respiratory health effects of exposure to low levels of airborne endotoxin—a systematic review. Environ Health. 2018; 17:14. doi:10.1186/s12940-018-0360-3
125. Park JH, Spiegelman DL, Gold DR, Burge HA, Milton DK. Predictors of airborne endotoxin in the home. Environ Health Perspect. 2001;109(8):859–864. doi:10.1289/ehp.01109859
126. Wheeler AJ, Wallace LA, Kearney J, et al. Residential indoor and outdoor coarse particles and associated endotoxin exposures. Atmos Environ. 2011;45(39):7064–7071. doi: 10.1016/j.atmosenv.2011.09.005
127. Rioufol C, Devys C, Meunier G, Perraud M, Goullet D. Quantitative determination of endotoxins released by bacterial biofilms. J Hosp Infect. 1999;43(3):203–209. doi:10.1053/jhin.1999.0673
128. Ledwoch K, Dancer SJ, Otter JA, Kerr K, Randle J. It is a trap! The development of a versatile drain biofilm model and its susceptibility to disinfection. J Hosp Infect. 2020;106(4):757–764. doi: 10.1016/j.jhin.2020.09.015
129. Park, Ju-Hyeong, et al. "Longitudinal Study of Dust and Airborne Endotoxin in the Home." Environmental Health Perspectives, vol. 108, no. 11, 2000, pp. 1023–1028. https://doi.org/10.1289/ehp.001081023.
130. Rintala H, Pitkäranta M. Actinobacteria in indoor environments: Exposure and potential health risks. Front Microbiol. 2021; 12:678536. doi:10.3389/fmicb.2021.678536
131. Mendell MJ, Mirer AG, Cheung K, Tong M, Douwes J. Respiratory and allergic health effects of dampness, mold, and dampness-related agents: a review of the epidemiologic evidence. Environ Health Perspect. 2011;119(6):748–756. doi:10.1289/ehp.1002410
132. Shoemaker, Ryan, et al. "Exposure to Actinobacteria Resident in Water Damaged Buildings and Resultant Immune Injury in Chronic Inflammatory Response Syndrome." Medical Research Archives, vol. 9, no. 10, Oct. 2021, https://doi.org/10.18103/mra.v9i10.2585.
133. Eduard W. Fungal spores: a critical review of the toxicological and epidemiological evidence as a basis for occupational exposure limit setting. Crit Rev Toxicol. 2009;39(10):799–864. doi:10.3109/10408440903307333
134. Shoemaker RC, et al. Endotoxins and Actinomycetes: Contaminants of water-damaged buildings with potential health effects. Surviving Mold. 2021. Accessed July 1, 2025. https://www.survivingmold.com/legal-resources/actino-central
135. Shoemaker RC. How Actinobacteria cause CIRS. Surviving Mold. 2022. Accessed July 1, 2025. https://www.survivingmold.com/legal-resources/actino-central
136. Green BJ, Cox-Ganser JM. Approaches to assessing microbial exposures in the indoor environment: recent advances and recommendations. Curr Environ Health Rep. 2021;8(2):104–113. doi:10.1007/s40572-021-00301-z
137. US Environmental Protection Agency. What does mold smell like? Moldy/musty odors and mVOCs. Accessed July 1, 2025. https://www.epa.gov/mold/what-does-mold-smell-moldymusty-odors-and-mvocs
138. US Environmental Protection Agency. Mold course chapter 3. Accessed July 1, 2025. https://www.epa.gov/mold/mold-course-chapter-3
139. National Institute for Occupational Safety and Health (NIOSH). Dampness and Mold Assessment Tool (DMAT). Accessed July 1, 2025. https://www.cdc.gov/niosh/topics/indoorenv/dampness-mold-assessment-tool.html
140. UpToDate. Assessment of mold in the indoor environment. Accessed July 1, 2025. https://www.uptodate.com/contents/assessment-of-mold-in-the-indoor-environment
141. New York City Department of Health and Mental Hygiene. Guidelines on assessment and remediation of fungi in indoor environments. 2008. Accessed July 1, 2025. https://www.nyc.gov/assets/doh/downloads/pdf/epi/epi-mold-guidelines.pdf
142. Kates OS. What is ethically important about antimicrobial resistance? AMA J Ethics. 2024;26(5): E363–366.
143. Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229–241.
144. Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ. Antifungal exposure and resistance development: a review of environmental selection pressures. Front Fungal Biol. 2022; 3:918717. doi:10.3389/ffunb.2022.918717
145. van der Torre M, Varga J, Stielow B, et al. Elevated mutation rates in multi-azole-resistant Aspergillus fumigatus drive rapid evolution of antifungal resistance. Nat Genet. 2024;56(1):123-131. doi:10.1038/s41588-024-54568-5
146. Shoemaker RC. Surviving Mold: Life in the Era of Dangerous Buildings. Washington, DC: Gateway Press; 2011:77.
147. Shoemaker RC. Mold Warriors: Fighting America's Hidden Health Threat. Havertown, PA: Gateway Press; 2005:100-110.
148. National Air Duct Cleaners Association. ACR: The NADCA Standard for Assessment, Cleaning & Restoration of HVAC Systems. Washington, DC: NADCA; 2021. Available at: https://nadca.com/industry/standards/ACR. Accessed July 1, 2025.
149. Moon RE. Assessment of cleaning efficacy for clothing contaminated in a mold-contaminated environment. Restoration Industry Association Journal. 2006;24(3):32–37.
150. Connecticut Department of Public Health. CT Guidelines for Mold Abatement Contractors. Rev. ed. Environmental Health Section; February 2023. https://portal.ct.gov/DPH. Accessed July 1, 2025.
151. Gravesen S, Frisvad JC, Samson RA. Microfungi. Copenhagen, Denmark: Munksgaard; 1994.
2. United States Environmental Protection Agency (EPA). Indoor Air Facts No. 4 (Revised): Sick Building Syndrome. EPA 402-F-94-004. Washington, DC: US EPA; 1991. Accessed June 20, 2025. https://www.epa.gov/sites/default/files/2014-08/documents/sick_building_factsheet.pdf
3. World Health Organization (WHO). Indoor Air Quality: Biological Contaminants: Report on a WHO Meeting. European Series No. 31. Copenhagen, Denmark: WHO Regional Office for Europe; 2009. Accessed June 20, 2025. https://iris.who.int/handle/10665/260557
4. Sundell J. What we know, and don't know about sick building syndrome. ASHRAE J. 1996;38(6).
5. Seppänen O, Fisk WJ, Mendell MJ. Association of ventilation rates and CO₂ concentrations with health and other responses in commercial and institutional buildings. Indoor Air. 1999;9(4):226–252. doi:10.1111/j.1600-0668.1999. 00003.x
6. Sundell J. On the history of indoor air quality and health. Indoor Air. 2004;14(Suppl 7):51–58. doi:10.1111/j.1600-0668.2004. 00273.x
7. Joshi SM. The sick building syndrome. Indian J Occup Environ Med. 2008 ;12(2) :61–64.
8. Chawla H, Anand P, Garg K, et al. A comprehensive review of microbial contamination in the indoor environment: sources, sampling, health risks, and mitigation strategies. Front Public Health. 2023; 11:1285393. doi:10.3389/fpubh.2023.1285393
9. New York City Department of Health. Guidelines on Assessment and Remediation of Stachybotrys atra in Indoor Environments. New York, NY: New York City Department of Health; 1993.
10. New York City Department of Health and Mental Hygiene, Bureau of Environmental & Occupational Disease Epidemiology. Guidelines on Assessment and Remediation of Fungi in Indoor Environments. New York, NY: NYC DOHMH; 2000.
11. American Conference of Governmental Industrial Hygienists. Bioaerosols: Assessment and Control. Cincinnati, OH: ACGIH; 1999.
12. US Environmental Protection Agency. Mold Remediation in Schools and Commercial Buildings. EPA 402-K-01-001. Washington, DC: US Environmental Protection Agency; 2001.
13. Górny RL, Reponen T, Willeke K, Schmechel D, Robine E, Boissier M, Grinshpun SA. Fungal fragments as indoor air biocontaminants. Appl Environ Microbiol. 2002;68(7):3522–3531. doi:10.1128/AEM.68.7.3522-3531.2002
14. Górny RL, Reponen T, Willeke K, et al. Release of fungal fragments in relation to fungal spore release from contaminated building materials. J Aerosol Sci. 2002;33(10):1319–1332. doi:10.1016/S0021-8502(02)00066-9
15. Brasel TL, Martin JM, Carriker CG, Wilson SC, Straus DC. Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins on particulates smaller than conidia. Appl Environ Microbiol. 2005;71(1):114–122. doi:10.1128/AEM.71.1.114-122.2005
16. Cho SH, Seo SC, Schmechel D, Grinshpun SA, Reponen T. Aerodynamic characteristics and respiratory deposition of fungal fragments. Atmos Environ. 2005;39(30):5454–5465. doi: 10.1016/j.atmosenv.2005.05.029
17. Reponen T, Seo SC, Grimsley F, Lee T, Crawford C, Grinshpun SA. Fungal fragments in moldy houses: a field study in homes in New Orleans and southern Ohio. Atmos Environ. 2007;41(37):8140–8149. doi: 10.1016/j.atmosenv.2007.06.004
18. Adhikari A, Reponen T, Rylander R. Airborne fungal cell fragments in homes in relation to total fungal biomass. Indoor Air. 2013;23(1):1–6. doi:10.1111/j.1600-0668.2012. 00799.x
19. Seo SC, Ji YG, Yoo Y, Kwon MH, Choung JT. Submicron fungal fragments as another indoor biocontaminant in elementary schools. Environ Sci Process Impacts. 2015;17(6):1164–1172. doi:10.1039/c5em00104k
20. Lee T, Grimsley F, Seo SC, Reponen T, Grinshpun SA. The level of submicron fungal fragments in homes with asthmatic children. Environ Res. 2014; 131:71–76. doi: 10.1016/j.envres.2014.02.014
21. Institute of Inspection, Cleaning and Restoration Certification (IICRC). IICRC S500: Standard and Reference Guide for Professional Water Damage Restoration. 2nd ed. Vancouver, WA: IICRC; 1999.
22. Institute of Inspection, Cleaning and Restoration Certification (IICRC). IICRC S520: Standard and Reference Guide for Professional Mold Remediation. 1st ed. Vancouver, WA: IICRC; 2003.
23. Institute of Inspection, Cleaning and Restoration Certification (IICRC). ANSI/IICRC S520-2024: Standard for Professional Mold Remediation. 4th ed. Las Vegas, NV: Institute of Inspection, Cleaning and Restoration Certification; 2024.
24. Banta JC, Passmore C, Holland J. Modeling the equilibrium spore load of a building. In: Johanning E, ed. Bioaerosols, Fungi, Bacteria, Mycotoxins, and Human Health. Albany, NY: Fungal Research Group Foundation; 2005:262–269.
25. Hardin BD, Kelman BJ, Saxon A. Adverse human health effects associated with molds in the indoor environment. J Occup Environ Med. 2003;45(5):470–478. doi: 10.1097/01.jom.0000069239.19784.5b
26. Kelman BJ. Deposition of Bruce J. Kelman (Kelman & GlobalTox, Inc. v. Kramer). July 22, 2008. Accessed July 1, 2025. https://katysexposure.com/wp-content/uploads/2021/03/kelman-deposition-july-22-2008-kelman-and-globaltox-v-kramer.pdf
27. Kramer S. Petition for Rehearing, Case No. D054496 / D047758, California Court of Appeal. October 22, 2010. Accessed July 1, 2025. https://katysexposure.com/wp-content/uploads/2021/03/10.22.10-final-petition-to-ca-supreme-ct-w-exhibilts.pdf
28. Mold-Help.org. Mold health rights advocate is sued by GlobalTox (now Veritox). Published June 2006. Accessed July 1, 2025. https://www.mold-help.org/mold-health-rights-advocate-sued-by-globaltox-now-veritox
29. Adamy J. Amid suits over mold, experts wear two hats. Wall Street Journal. February 7, 2007. Reprinted by WonderMakers Environmental. Accessed July 1, 2025. https://www.wondermakers.com/Portals/0/docs/02.%20Amid%20Suits%20Over%20Mold%20Experts%20Wear%20Two%20Hats%2002.07.pdf
30. Craner J. A critique of the ACOEM statement on mold: undisclosed conflicts of interest in the creation of an "evidence-based" statement. Int J Occup Environ Health. 2008;14(4):283–298. doi:10.1179/oeh.2008.14.4.283
31. Storey E, Dangman KH, Schenck P, et al. Guidance for Clinicians on the Recognition and Management of Health Effects Related to Mold Exposure and Moisture Indoors. Farmington, CT: University of Connecticut Health Center, Division of Occupational and Environmental Medicine, Center for Indoor Environments and Health; 2004.
32. Haugland RA, Vesper SJ. Method of identifying and quantifying specific fungi and bacteria. US patent 6,387,652 B1. May 14, 2002. Assigned to the US Environmental Protection Agency.
33. Vesper SJ. Mold specific quantitative PCR for rapid identification and enumeration. Presented at: 7th Annual Army Force Health Protection Conference; August 6–12, 2004; Albuquerque, NM.
34. Vesper SJ, Haugland C, Barnes C, Reponen F, Grinshpun SA. Development of an environmental relative moldiness index for US homes. Appl Environ Microbiol. 2007;73(11):346–356.
35. Vesper SJ. The development and application of the Environmental Relative Moldiness Index (ERMI). Crit Rev Microbiol. 2024;51(2):285–295. doi:10.1080/1040841X.2024.2344112
36. World Health Organization. WHO Guidelines for Indoor Air Quality: Dampness and mold. Copenhagen, Denmark: WHO Regional Office for Europe; 2009.
37. Institute of Medicine (US) Committee on Damp Indoor Spaces and Health. Damp Indoor Spaces and Health. Washington, DC: National Academies Press; 2004. Chapter 6, Prevention and remediation of damp indoor environments. Accessed July 1, 2025. https://www.ncbi.nlm.nih.gov/books/NBK215647/
38. American National Standards Institute (ANSI). ANSI Essential Requirements: Due Process Requirements for American National Standards. ANSI; 2024. Accessed July 1, 2025. https://www.ansi.org/essentialrequirements
39. US Government Accountability Office. Indoor Mold: Better Coordination of Research on Health Effects and More Consistent Guidance Would Improve Federal Efforts. GAO-08-980. Washington, DC: US Government Accountability Office; September 2008.
40. Shoemaker RC, Johnson K, Jim L, et al. Diagnostic process for chronic inflammatory response syndrome (CIRS): a consensus statement. Intern Med Rev. 2018;4(5):1–47.
41. Shoemaker RC, Lark D. HERTSMI-2 and ERMI: correlating human health risk with mold-specific qPCR in water-damaged buildings. Presented at: 14th International Conference on Indoor Air Quality and Climate; May 2016; Ghent, Belgium.
42. Shoemaker RC, House DE. Sick building syndrome in water-damaged buildings: generalization of the chronic biotoxin-associated illness paradigm to indoor toxigenic fungi exposure. Neurotoxicol Teratol. 2006;28(5):573–588. doi: 10.1016/j.ntt.2006.07.007
43. Shoemaker RC, Maizel M. Exposure to water-damaged buildings causes a readily identifiable chronic inflammatory response syndrome that is successfully treated by a sequential intervention protocol. Presented at: International Mycological Congress 9; 2010; Edinburgh, Scotland.
44. Flannigan B, Samson RA, Miller JD, eds. Microorganisms in Home and Indoor Work Environments: Diversity, Health Impacts, Investigation and Control. London, UK: Taylor & Francis; 2001.
45. Banta JC. Mold Controlled: A Guide to Finding, Fixing, Preventing, and Getting Help with Mold Problems in Homes. John C. Banta Publishing; 2025.
46. CIRSx Institute. Medically Important Remediation for Professionals (MIR 101) [online course]. 14 CE hours. CIRSx Institute; 2024. Accessed July 1, 2025. https://institute.cirsx.com/course/mir101
47. Halverson M, Christian J. Managing the drivers of airflow and water vapor transit in existing buildings. Building America Technical Update. US Department of Energy; April 2011.
48. US Department of Housing and Urban Development. Minimizing Moisture Problems in Manufactured Homes: Response of Interior Air Pressures to Operating Conditions. HUD; June 2003.
49. World Health Organization. Moisture Control Guidance for Building Design, Construction, and Maintenance. Adapted by US Environmental Protection Agency; December 2013.
50. Schwartz L, Schrantz M, Weatherman G, Charlton J, Shoemaker R. Surviving Mold Consensus Statement: Medically Sound Investigation and Remediation of Water-Damaged Buildings in Cases of CIRS-WDB. SurvivingMold.com; 2016. Accessed July 1, 2025. https://www.survivingmold.com/docs/IEP_CONSENSUS_04_12_16.pdf
51. CIRSx Institute. Medically Important Assessment for Professionals (MIA 101) [online course]. CIRSx Institute; 2024. Accessed July 1, 2025. https://institute.cirsx.com/payment?product_id=mia101
52. CIRSx Institute. Medically Important Assessment for Consultants (MIA 102) [online course]. CIRSx Institute; 2024. Accessed July 1, 2025. https://institute.cirsx.com/payment?product_id=mia102
53. Lstiburek JW, Eng P. Understanding vapor barriers. ASHRAE J. 2004; 46:40–51.
54. Lstiburek JW. Toward an Understanding and Prediction of Air Flow in Buildings [doctoral dissertation]. 2000.
55. Lstiburek J, Pressnail K, Timusk J. Air pressure and building envelopes. J Therm Envel Build Sci. 2002;26(1):53–91. doi:10.1177/1097196302026001570
56. Lstiburek J. Moisture control for buildings. ASHRAE J. 2002;44(2):36–41.
57. Lstiburek JW. The Pressure Response of Buildings. 1998.
58. Cox DJ, Seitz RW, Anderson RA. Mold growth and carbon dioxide production during storage of moist grain. Cereal Chem. 1985;62(2):137–142.
59. Smith J, Rhoades M, Taylor C, et al. Assessment of microbial activity by CO₂ production during heating-oil storage. Appl Environ Microbiol. 2023; e00934-23. doi:10.1128/aem.00934-23
60. Koruba D, Piotrowski JZ. Effect of high CO₂ concentrations on the molds' growth and morphology present in the indoor air. Proc Kielce Univ Technol Fac Civil Environ Eng Sect. 2021.
61. United States Environmental Protection Agency. Mold course chapter 1: introduction to molds. EPA. December 20, 2024. Accessed June 20, 2025. https://www.epa.gov/mold/mold-course-chapter-1
62. Centers for Disease Control and Prevention. Mold prevention strategies and possible health effects in the aftermath of hurricanes and major floods. MMWR Recomm Rep. 2006;55(RR-8):1–27. Accessed June 20, 2025. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5508a1.htm
63. Cho SH, Seo SC, Schmechel D, Grinshpun SA, Reponen T. Aerodynamic characteristics and respiratory deposition of fungal fragments. Atmos Environ. 2005;39(30):5454–5465. doi: 10.1016/j.atmosenv.2005.05.029
64. Reponen T, Seo SC, Grimsley F, Lee T, Crawford C, Grinshpun SA. Fungal fragments in moldy houses: a field study in homes in New Orleans and southern Ohio. Atmos Environ. 2007;41(37):8140–8149. doi: 10.1016/j.atmosenv.2007.06.004
65. Hooke R. Micrographia: or Some Physiological Descriptions of Minute Bodies Made by Magnifying Glasses. London, UK: J. Martyn and J. Allestry; 1665.
66. Black WD. A comparison of several media types and basic techniques used to assess outdoor airborne fungi in Melbourne, Australia. PLoS One. 2020;15(12): e0238901. doi: 10.1371/journal.pone.0238901
67. EMSL Analytical, Inc. Microbiology Sampling Guide. Parsippany, NJ: EMSL Analytical, Inc.; 2019. Accessed July 1, 2025. https://emsl.com/PDFDocuments/SamplingGuide/Microbiology%20Sampling%20Guide.pdf
68. Flannigan B, Samson RA, Miller JD, eds. Microorganisms in Home and Indoor Work Environments: Diversity, Health Impacts, Investigation, and Control. 2nd ed. Boca Raton, FL: CRC Press; 2011:33.
69. Käpylä M, Penttinen A. An evaluation of the microscopic counting methods of the tape in Hirst-Burkard pollen and spore trap. Grana. 1981; 20:131–141.
70. Zhu H, Ge Y, Wang Y, et al. PCR past, present and future. Biotechniques. 2020;69(4):317–325. doi:10.2144/btn-2020-0082
71. Cox CS, Wathes CM. Bioaerosols in the environment. In: Cox CS, Wathes CM, eds. Bioaerosols Handbook. Boca Raton, FL: Lewis Publishers; 1995.
72. Nottrebart HS. Nosocomial infections acquired by hospital employees. Infect Control. 1980; 1:257–259.
73. Burge HA, Macher JM, Milton DK, Ammann HA. Data evaluation. In: Macher J, ed. Bioaerosols: Assessment and Control. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 1999.
74. Macher J, ed. Bioaerosols: Assessment and Control. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 1999.
75. Rubin J. Mycobacterial disinfection and control. In: Block SS, ed. Disinfection, Sterilization, and Preservation. 4th ed. Philadelphia, PA: Lea & Febiger; 1991.
76. Reinthaler FF, Haas D, Feierl G, et al. Comparative investigations of airborne culturable microorganisms in selected waste treatment facilities and in neighboring residential areas. Zentralbl Hyg Umweltmed. 1999; 202:1–17.
77. Reponen TA, Gazenko SV, Grinshpun SA, Willeke K, Cole EC. Characteristics of airborne actinomycete spores. Appl Environ Microbiol. 1998; 64:3807–3812.
78. Nevalainen A, Pasanen AL, Niininen M, Reponen T, Jantunen MJ, Kalliokoski P. The indoor air quality in Finnish homes with mold problems. Environ Int. 1991; 17:299–302.
79. Rautiala S, Reponen T, Hyvärinen A, et al. Exposure to airborne microbes during repair of moldy buildings. Am Ind Hyg Assoc J. 1996; 57:279–284.
80. Buttner MP, Stetzenbach LD. Monitoring of fungal spores in an experimental indoor environment to evaluate sampling methods and the effects of human activity on air sampling. Appl Environ Microbiol. 1993; 59:219–226.
81. Górny RL, Reponen T, Willeke K, Schmechel D, Robine E, Boissier M, Grinshpun SA. Fungal fragments as indoor air biocontaminants. Appl Environ Microbiol. 2002;68(7):3522–3531. doi:10.1128/AEM.68.7.3522-3531.2002
82. Lee T, Grimsley F, Seo SC, Reponen T, Grinshpun SA. The level of submicron fungal fragments in homes with asthmatic children. Environ Res. 2014; 131:71–76. doi: 10.1016/j.envres.2014.02.014
83. US Environmental Protection Agency. The Environmental Relative Moldiness Index (ERMI). EPA Science Inventory Fact Sheet; September 9, 2021.
84. Houbraken J, Frisvad JC, Samson RA, Westerdijk Fungal Biodiversity Institute. Classification of Aspergillus, Penicillium, Talaromyces, and related genera (Eurotiales): an overview of families, genera, subgenera, sections, series and species. Stud Mycol. 2021; 102:1–165. doi: 10.1016/j.simyco.2021.01.002
85. Samson RA, Frisvad JC, Hubka V, et al. Phylogeny, identification and nomenclature of the genus Aspergillus. Stud Mycol. 2014; 78:141–173. doi: 10.1016/j.simyco.2014.07.004
86. Lin KT, Schrantz M, Sandagdorj O, et al. Spore trap analysis and MSQPCR in evaluating mold burden: a flooded gymnasium case study. Front Biosci (Elite Ed). 2011;3(1):108–114.
87. Meklin T, Reponen T, McKinstry C, et al. Comparison of mold concentrations quantified by MSQPCR in indoor and outdoor air sampled simultaneously. Sci Total Environ. 2007;382(1):130–134. doi: 10.1016/j.scitotenv.2007.04.031
88. Lignell U, Meklin T, Rintala H, et al. Evaluation of quantitative PCR and culture methods for detection of house dust fungi and Streptomycetes in relation to moisture damage of the house. Lett Appl Microbiol. 2008;47(4):303–308. doi:10.1111/j.1472-765X.2008. 02441.x
89. Reponen T, Cho SH, Grinshpun SA, et al. Comparison of qPCR and culture-based methods for assessing indoor fungal exposure in homes with asthmatic children. Environ Sci Technol. 2008;42(7):2532–2538. doi:10.1021/es0715973
90. Vesper SJ. Traditional mold analysis compared to a DNA-based method of mold analysis. Crit Rev Microbiol. 2011;37(1):15–24. doi:10.3109/1040841X.2010.506177
91. Amin H, Balyan R, Patel K, et al. Indoor airborne microbiome and endotoxin: meteorological events and occupant characteristics are important determinants. Environ Sci Technol. 2023;57(32):11750–11766. doi: 10.1021/acs.est.3c02513
92. Amin H, Patel K, Balyan R, et al. Optimization of bacterial DNA and endotoxin extraction from settled airborne dust. Sci Total Environ. 2023; 857:159455. doi: 10.1016/j.scitotenv.2022.159455
93. Dungan RS, Leytem AB. Airborne endotoxin concentrations at a large open-lot dairy in southern Idaho. J Environ Qual. 2009;38(5):1919–1923. doi:10.2134/jeq2008.0459
94. Eduard W. Exposure to non-infectious microorganisms and endotoxins in agriculture. Ann Agric Environ Med. 1997;4(2):17–26.
95. Gioffrè A, Marramao A, Iannò A. Airborne microorganisms, endotoxin, and dust concentration in wood factories in Italy. Ann Occup Hyg. 2012;56(2):161–169. doi:10.1093/annhyg/mer089
96. Lang-Yona N, Aboaba O, Levin Y, et al. Air-sampled filter analysis for endotoxins and DNA content. J Vis Exp. 2016;(109): e53444. doi:10.3791/53444
97. Laitinen S, Kangas J, Kotimaa M, et al. Exposure to biological and chemical agents at biomass power plants. Biomass Bioenergy. 2016; 93:78–86. doi: 10.1016/j.biombioe.2016.06.003
98. Madsen AM. Airborne endotoxin in different background environments and seasons. Ann Agric Environ Med. 2006;13(1):81–86.
99. Rolph CA, Sunderraj T, Bowatte G, Lodge K, Jalaludin B, Knibbs LD. Sources of airborne endotoxins in ambient air and exposure of nearby communities—a review. Atmosphere. 2018;9(10):375. doi:10.3390/atmos9100375
100. Semple S, Apsley A, Azmina Ibrahim T, Turner S. Airborne endotoxin concentrations in homes burning biomass fuel. Environ Health Perspect. 2010;118(7):988–991. doi:10.1289/ehp.0901505
101. Shin SJ, Lee JY, Jeon BH, et al. Major environmental characteristics of swine husbandry that affect exposure to dust and airborne endotoxins. J Toxicol Environ Health A. 2019;82(4):233–243. doi:10.1080/15287394.2019.1596311
102. Siegel PD, Olenchock SA, Sorenson WG, et al. Histamine and endotoxin contamination of hay and respirable hay dust. Scand J Work Environ Health. 1991;17(4):276–280. doi:10.5271/sjweh.1705
103. Wheeler AJ, Stewart I, Donovan NJ, et al. Residential indoor and outdoor coarse particles and associated endotoxin exposures. Atmos Environ. 2011;45(39):7064–7071. doi: 10.1016/j.atmosenv.2011.09.007
104. Chhetry BS, Ahmad H, Jain R, Kumar S, Gaur R. Endotoxins affecting human health during agricultural practices: an overview. ApplChem. 2022;3(1):11–31. doi:10.3390/applchem3010002
105. Farokhi A, Heederik D, Smit LAM. Respiratory health effects of exposure to low levels of airborne endotoxin—a systematic review. Environ Health. 2018; 17:36. doi:10.1186/s12940-018-0380-6
106. Mendy A, Wilkerson J, Salo P, et al. Endotoxin clustering with allergens in house dust and asthma outcomes in a US national study. Environ Health. 2020; 19:28. doi:10.1186/s12940-020-00584-2
107. Thorne PS, Duchaine C. Airborne bacteria and endotoxin. In: Hurst CJ, Crawford RL, Garland JL, Lipson DA, Mills AL, Stetzenbach LD, eds. Manual of Environmental Microbiology. 3rd ed. Washington, DC: ASM Press; 2007:989–1004.
108. Douwes J, Thorne P, Pearce N, Heederik D. Endotoxin exposure in the workplace and residential environments: an overview of the health effects. Ann Agric Environ Med. 2002;9(2):253–268.
109. Shoemaker RC, Heyman A, Dorninger E, McMahon S, Lark D. A novel therapeutic approach to Parkinson's disease: using transcriptomics to identify unique patterns of gene expression including "triple positives," toll receptors, and endotoxin exposure. Med Res Arch. 2024;12(9). Accessed July 1, 2025. https://journals.ke-i.org/index.php/mra/article/view/6652
110. Fei-Yong Z, Zhang O, Zhang J, Lou Z, et al. The synergy of aging and LPS exposure in a mouse model of Parkinson's disease. Aging Dis. 2018; 5:785–797. doi:10.14336/AD.2018.0706
111. Brown G. The endotoxin hypothesis of neurodegeneration. J Neuroinflammation. 2019; 16:180. doi:10.1186/s12974-019-1575-2
112. Batista C, Gomes G, Candelario-Jalil E, Fiebich B, et al. Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration. Int J Mol Sci. 2019;20(9):2293. doi:10.3390/ijms20092293
113. Gu C, Wang F, Zhang Y, et al. Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming. Aging Cell. 2021;20(4): e13375. doi:10.1111/acel.13375
114. Wu L, Block M, Breese G, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55(5):453–462. doi:10.1002/glia.20467
115. Skrzypczak-Wiercioch A, Salat K. Lipopolysaccharide-induced model neuroinflammation: mechanisms of action, research application and future directions for its use. Molecules. 2022;27(2):548. doi:10.3390/molecules27020548
116. Bai L, Zhang X, Li X, et al. Somatostatin prevents LPS-induced neurodegeneration in the rat substantia nigra by inhibiting the action of microglia. Mol Med Rep. 2015;12(1):1002–1008. doi:10.3892/mmr.2015.3516
117. U.S. Food and Drug Administration. Bacterial Endotoxins/Pyrogens (USP <85>). FDA. Accessed June 20, 2025. https://www.fda.gov/media/83477/download
118. Maloney J, Nguyen HM, McMahon S. Use of recombinant factor C (rFC) assay in endotoxin testing: an alternative to Limulus amebocyte lysate. J Pharm Sci. 2021;110(4):1453–1459. doi: 10.1016/j.xphs.2020.12.012
119. Laitinen, Sirpa, et al. "Exposure to Biological and Chemical Agents at Biomass Power Plants." Biomass and Bioenergy, vol. 93, 2016, pp. 78–86.
120. Dungan RS, Leytem AB. Airborne endotoxin concentrations at a large open-lot dairy in southern Idaho. J Environ Qual. 2009;38(5):1919–1923. doi:10.2134/jeq2008.0422
121. Shin SJ, Choi SJ, Lee CH, et al. Major environmental characteristics of swine husbandry that affect exposure to dust and airborne endotoxins. J Toxicol Environ Health A. 2019;82(4):233–243. doi:10.1080/15287394.2019.1592100
122. De Rooij MMT, Smit LAM, Erbrink M, et al. Short-term residential exposure to endotoxin emitted from livestock farms in relation to lung function in non-farming residents. Environ Res. 2024; 243:117821. doi: 10.1016/j.envres.2024.117821
123. De Rooij MMT, Smit LAM, Erbrink M, et al. Endotoxin and particulate matter emitted by livestock farms and respiratory health effects in neighboring residents. Environ Int. 2019; 132:105009. doi: 10.1016/j.envint.2019.105009
124. Farokhi A, Heederik D, Smit LAM. Respiratory health effects of exposure to low levels of airborne endotoxin—a systematic review. Environ Health. 2018; 17:14. doi:10.1186/s12940-018-0360-3
125. Park JH, Spiegelman DL, Gold DR, Burge HA, Milton DK. Predictors of airborne endotoxin in the home. Environ Health Perspect. 2001;109(8):859–864. doi:10.1289/ehp.01109859
126. Wheeler AJ, Wallace LA, Kearney J, et al. Residential indoor and outdoor coarse particles and associated endotoxin exposures. Atmos Environ. 2011;45(39):7064–7071. doi: 10.1016/j.atmosenv.2011.09.005
127. Rioufol C, Devys C, Meunier G, Perraud M, Goullet D. Quantitative determination of endotoxins released by bacterial biofilms. J Hosp Infect. 1999;43(3):203–209. doi:10.1053/jhin.1999.0673
128. Ledwoch K, Dancer SJ, Otter JA, Kerr K, Randle J. It is a trap! The development of a versatile drain biofilm model and its susceptibility to disinfection. J Hosp Infect. 2020;106(4):757–764. doi: 10.1016/j.jhin.2020.09.015
129. Park, Ju-Hyeong, et al. "Longitudinal Study of Dust and Airborne Endotoxin in the Home." Environmental Health Perspectives, vol. 108, no. 11, 2000, pp. 1023–1028. https://doi.org/10.1289/ehp.001081023.
130. Rintala H, Pitkäranta M. Actinobacteria in indoor environments: Exposure and potential health risks. Front Microbiol. 2021; 12:678536. doi:10.3389/fmicb.2021.678536
131. Mendell MJ, Mirer AG, Cheung K, Tong M, Douwes J. Respiratory and allergic health effects of dampness, mold, and dampness-related agents: a review of the epidemiologic evidence. Environ Health Perspect. 2011;119(6):748–756. doi:10.1289/ehp.1002410
132. Shoemaker, Ryan, et al. "Exposure to Actinobacteria Resident in Water Damaged Buildings and Resultant Immune Injury in Chronic Inflammatory Response Syndrome." Medical Research Archives, vol. 9, no. 10, Oct. 2021, https://doi.org/10.18103/mra.v9i10.2585.
133. Eduard W. Fungal spores: a critical review of the toxicological and epidemiological evidence as a basis for occupational exposure limit setting. Crit Rev Toxicol. 2009;39(10):799–864. doi:10.3109/10408440903307333
134. Shoemaker RC, et al. Endotoxins and Actinomycetes: Contaminants of water-damaged buildings with potential health effects. Surviving Mold. 2021. Accessed July 1, 2025. https://www.survivingmold.com/legal-resources/actino-central
135. Shoemaker RC. How Actinobacteria cause CIRS. Surviving Mold. 2022. Accessed July 1, 2025. https://www.survivingmold.com/legal-resources/actino-central
136. Green BJ, Cox-Ganser JM. Approaches to assessing microbial exposures in the indoor environment: recent advances and recommendations. Curr Environ Health Rep. 2021;8(2):104–113. doi:10.1007/s40572-021-00301-z
137. US Environmental Protection Agency. What does mold smell like? Moldy/musty odors and mVOCs. Accessed July 1, 2025. https://www.epa.gov/mold/what-does-mold-smell-moldymusty-odors-and-mvocs
138. US Environmental Protection Agency. Mold course chapter 3. Accessed July 1, 2025. https://www.epa.gov/mold/mold-course-chapter-3
139. National Institute for Occupational Safety and Health (NIOSH). Dampness and Mold Assessment Tool (DMAT). Accessed July 1, 2025. https://www.cdc.gov/niosh/topics/indoorenv/dampness-mold-assessment-tool.html
140. UpToDate. Assessment of mold in the indoor environment. Accessed July 1, 2025. https://www.uptodate.com/contents/assessment-of-mold-in-the-indoor-environment
141. New York City Department of Health and Mental Hygiene. Guidelines on assessment and remediation of fungi in indoor environments. 2008. Accessed July 1, 2025. https://www.nyc.gov/assets/doh/downloads/pdf/epi/epi-mold-guidelines.pdf
142. Kates OS. What is ethically important about antimicrobial resistance? AMA J Ethics. 2024;26(5): E363–366.
143. Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229–241.
144. Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ. Antifungal exposure and resistance development: a review of environmental selection pressures. Front Fungal Biol. 2022; 3:918717. doi:10.3389/ffunb.2022.918717
145. van der Torre M, Varga J, Stielow B, et al. Elevated mutation rates in multi-azole-resistant Aspergillus fumigatus drive rapid evolution of antifungal resistance. Nat Genet. 2024;56(1):123-131. doi:10.1038/s41588-024-54568-5
146. Shoemaker RC. Surviving Mold: Life in the Era of Dangerous Buildings. Washington, DC: Gateway Press; 2011:77.
147. Shoemaker RC. Mold Warriors: Fighting America's Hidden Health Threat. Havertown, PA: Gateway Press; 2005:100-110.
148. National Air Duct Cleaners Association. ACR: The NADCA Standard for Assessment, Cleaning & Restoration of HVAC Systems. Washington, DC: NADCA; 2021. Available at: https://nadca.com/industry/standards/ACR. Accessed July 1, 2025.
149. Moon RE. Assessment of cleaning efficacy for clothing contaminated in a mold-contaminated environment. Restoration Industry Association Journal. 2006;24(3):32–37.
150. Connecticut Department of Public Health. CT Guidelines for Mold Abatement Contractors. Rev. ed. Environmental Health Section; February 2023. https://portal.ct.gov/DPH. Accessed July 1, 2025.
151. Gravesen S, Frisvad JC, Samson RA. Microfungi. Copenhagen, Denmark: Munksgaard; 1994.